Oligometastases/Oligo-Recurrence of Lung Cancer

<table class="table-group" id="tab1"><tr><td><table class="table"><tr><td class="thead-hr" colspan="4"><hr/></td></tr><tr class="thead"><td align="left" rowspan="2">Favorable</td><td align="left" colspan="2">
							Intermediate</td><td align="left" rowspan="1">
							Unfavorable</td></tr><tr class="thead"><td align="left">Relatively favorable</td><td align="left">Relatively unfavorable</td></tr><tr><td class="thead-hr" colspan="4"><hr/></td></tr><tr><td align="left">Oligorecurrence  Site no. 1-2 NSCLC (brain and adrenal gland) Colon and rectum cancer (lung and liver) Renal cell cancer</td><td align="left">oligo-recurrence  site no. 1-2 breast cancer (bone, lung, and liver) SCLC (brain) site no. 3–5 NSCLC (brain and adrenal gland) colon and rectum cancer (lung and liver) renal cell cancer</td><td align="left">oligo-recurrence  site no. 3–5 breast cancer (bone, lung, and liver) SCLC (brain)</td><td align="left">Oligometastases and oligo-recurrence  pancreatic cancer (any site) melanoma (any site) sarcoma (any site)</td></tr><tr><td align="left"> </td><td align="left"> sync-oligometastases  site no. 1-2 NSCLC (brain and adrenal gland) colon and rectum cancer (lung and liver) renal cell cancer</td><td align="left">sync-oligometastases  site no. 3–5 NSCLC (brain and adrenal gland) colon and rectum cancer (lung and liver) breast cancer (bone, lung, and liver)</td><td align="left">polymetastases </td></tr><tr class="table-tr"><td colspan="4"><hr class="tbody-hr"/></td></tr></table></td></tr></table>

Pulmonary Medicine

tab1

Table 1

Table 1: Oligometastases/Oligo-Recurrence of Lung Cancer 